This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Navigating the complexities of pharma and biotech packaging services can be difficult. With the growing number of complex therapies that require specialized packaging and handling requirements, selecting the right contractpackaging organization (CPO) involves evaluating what services and additional benefits they can bring to your business.
Understanding the Role of a Blister Packaging Supplier Before looking into the selection process, it’s vital to understand the role of a contractpackaging organisation blister packaging supplier. Material Selection Central to the blister packaging process is the selection of appropriate materials.
Large (market cap $10–100bn) and mega-cap (market cap >$100bn) sponsors also require contractmanufacturers and packagers with specialist injectable capabilities in the case of cell and gene therapies, as shown in the report titled Contract Injectable Packaging Trends in the Bio/Pharma Industry (August 2022).
The pharmaceutical industry requires specialised and cost-effective commercial packaging solutions to improve efficiency and preserve the integrity of products through the entire supply chain, from primary packaging and labelling to shipping, delivery, storage and distribution to end users. Trends in pharmaceutical contractpackaging.
Unlike commercial pharmaceutical packaging, the primary consideration in clinical trial packaging is protecting the product quality and reliability for research. Finding the best clinical trial packaging services providers.
With unprecedented demand for products manufactured in the US and potential trade disruption challenges, we do offer our domestic contractpackaging services as a backup. Companies may wish to plan now to ensure registrations for a US-based CMO are in place to allow a quick change should it become critical.
During my thirty fours years in the packaging business, I have realized packaging touches more departments than any other component purchased by our customers. The marketing department is always engaged considering the package is the first impression impacting the customer. This thought process provides the impetus to improve.
Startup sets out to tackle the gene therapy manufacturing crisis ( Endpoints ).
BD Taps ContractPackager for COVID-19 Test Kits ( MD+DI ).
A Digitalization Tipping Point for the Medical Manufacturing Supply Chain ( MD+DI ).
Medtech.
Government & Regulatory.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content